AstraZeneca's up to $1.46 billion deal with insitro bets on an AI platform that grows lab cells to uncover the causal biology behind fatty liver disease, though the partnership remains at its earliest, highest-risk stage.
Wellysis's FDA-cleared S-Patch CardioAI joins a list of more than 1,600 AI-enabled medical devices, even as the FDA weighs new rules specifically for generative AI devices that could reshape the approval pathway.
The UK's Medical Protection Society says AI-generated patient complaints, sometimes exceeding 20 pages, are adding to GPs' administrative burden even as AI tools simultaneously ease their documentation workload elsewhere.
HHS's $1.5 million grant to MedStar and Regenstrief targets two persistent healthcare AI bottlenecks: patient control over AI workflows and laboratory data interoperability between health systems.
Czech researchers have unveiled DigiDiaDem, an AI-powered application designed to help identify the first symptoms of dementia earlier than conventional screening, adding to a growing field of digital tools aimed at early cognitive decline detection.
Twin Cities Community Hospital and Sierra Vista Regional Medical Center in San Luis Obispo County are using Viz.ai software to read CT scans for stroke symptoms within minutes, part of a growing wave of AI-assisted stroke care in community hospitals.
Ardent Health's chief medical information officer, Brad Hoyt, says the system's ambient AI documentation tool is saving physicians about three hours a week, part of a broader industry push to use AI to cut clinician burnout.
Startup Natura launched a $99 smart ring called Interface on October 8, 2026, that lets wearers summon AI agents like Claude and ChatGPT with a finger press while also tracking heart rate, sleep, and activity.
Slingshot AI pulled its Ash therapy chatbot from the UK over medical-device regulatory concerns in January 2026, then pivoted in May to clinical trials pairing the chatbot with licensed human therapists.
At its second annual London Innovation Summit on October 7, 2026, Cleveland Clinic disclosed a new AI research pilot with IBM to study how routine surgeries affect patients' long-term health and quality of life, drawing on imaging and clinical data from its London BioResource. The announcement came alongside summit sessions on AI-enabled robotics and the 'connected operating room.'